DTC · Supplements
Subscription churn was masked by aggressive new-trial spend.
This marketing & margin audit surfaced $55k in recurring annual margin in a DTC / Ecommerce business — evidenced, senior-reviewed, and delivered in 7 days.
The business
A supplements brand looked like a textbook subscription success. Trials were cheap to acquire, the subscriber count climbed every month, and the growth chart went reliably up and to the right in every board meeting. Confidence was high enough that the team was planning to pour more budget into the same low-cost trial acquisition that appeared to be driving the whole story forward.
What triggered the audit
Despite the encouraging chart, cash always felt tighter than the growth implied, and the founders couldn’t reconcile the two. The audit stress-tested the business model the only way that genuinely matters for a subscription: it stripped the trial incentives out of the numbers and watched how the acquired cohorts actually behaved once the discount stopped propping them up.
What the audit found
Underneath the healthy headline, the retention engine was running backwards. Once the trial incentives were removed from the analysis, net revenue retention was below 100% — subscribers were churning faster than the base was being retained and expanded, so the business was structurally leaking value with every cohort. The rising subscriber count wasn’t evidence of a healthy product; it was the visible result of aggressive new-trial spend continually refilling a leaking bucket faster than it drained. The moment acquisition slowed, the whole model would contract. The brand had been mistaking the momentum of cheap trials for genuine growth, and the true health of each cohort had been completely obscured by the volume of new ones arriving on top.
What we changed
Reset acquisition to target cohorts with proven month-three retention, rather than simply chasing the lowest possible trial cost regardless of whether those users stay.
Reworked the post-trial onboarding flow to convert and hold subscribers into a durable habit, instead of relying on a constant stream of new trials to mask churn.
Made net revenue retention the headline metric the team manages to, so the real health of the base is always visible rather than hidden behind gross sign-ups.
Rebalanced spend toward retention and expansion of existing subscribers, where the economics actually compound.
The result
Net retention swung to +24% once spend chased durable cohorts instead of vanity trials. Any subscription leader should sit up here: the growth chart pointed up and to the right the entire time the model was leaking value, because new trials refilled the bucket faster than it drained. If your acquisition is cheap and your churn is quietly high, you may be mistaking momentum for growth — and it unravels the moment spend slows. A structured audit strips the incentives out and shows the truth in days, while there is still runway to fix it.
From kickoff to signed-off findings: 7 days — inside our fixed 5–7 day window.
This +24% net retention gain is ≈$55k/yr at the client’s revenue scale.